Marina Aghababyan, MD | |
450 Chew St, Allentown, PA 18102-3434 | |
(610) 776-4888 | |
(610) 776-4895 |
Full Name | Marina Aghababyan |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 13 Years |
Location | 450 Chew St, Allentown, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700264611 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MT207774 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Austin Medical Center | Austin, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ipc Healthcare Services Of Texas Pllc | 3971824939 | 143 |
News Archive
Research in the current issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their "catch-up sleep" on the weekends, and they were involved in fewer auto accidents.
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
For people contemplating a hip or knee replacement, the prospect of a long post-surgical recovery can be a daunting one. The grueling rehabilitation sessions, the frustration of re-learning everyday movements, the weeks of waiting to return to "normal"— it's almost enough to make patients reconsider surgery.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 6 days ago
Entity Name | Lonestar Hospital Medicine Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518237429 PECOS PAC ID: 6709049703 Enrollment ID: O20120530000620 |
News Archive
Research in the current issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their "catch-up sleep" on the weekends, and they were involved in fewer auto accidents.
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
For people contemplating a hip or knee replacement, the prospect of a long post-surgical recovery can be a daunting one. The grueling rehabilitation sessions, the frustration of re-learning everyday movements, the weeks of waiting to return to "normal"— it's almost enough to make patients reconsider surgery.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 6 days ago
Entity Name | Ipc Healthcare Services Of Texas Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023403011 PECOS PAC ID: 3971824939 Enrollment ID: O20150603001409 |
News Archive
Research in the current issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their "catch-up sleep" on the weekends, and they were involved in fewer auto accidents.
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
For people contemplating a hip or knee replacement, the prospect of a long post-surgical recovery can be a daunting one. The grueling rehabilitation sessions, the frustration of re-learning everyday movements, the weeks of waiting to return to "normal"— it's almost enough to make patients reconsider surgery.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Marina Aghababyan, MD 450 Chew St, Allentown, PA 18102-3434 Ph: (610) 776-4888 | Marina Aghababyan, MD 450 Chew St, Allentown, PA 18102-3434 Ph: (610) 776-4888 |
News Archive
Research in the current issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their "catch-up sleep" on the weekends, and they were involved in fewer auto accidents.
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
For people contemplating a hip or knee replacement, the prospect of a long post-surgical recovery can be a daunting one. The grueling rehabilitation sessions, the frustration of re-learning everyday movements, the weeks of waiting to return to "normal"— it's almost enough to make patients reconsider surgery.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 6 days ago
Dr. Xander Arwand, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 110, Allentown, PA 18103 Phone: 610-402-8900 Fax: 610-402-5656 | |
John E Connelly, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 N 17th St, Suite # 108, Allentown, PA 18104 Phone: 610-434-4760 Fax: 610-820-9122 | |
Dr. Ann Marie Lam, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1251 S Cedar Crest Blvd, Suite 102 A, Allentown, PA 18103 Phone: 610-402-3940 Fax: 610-102-3950 | |
Leyland Robinson, Family Medicine Medicare: Medicare Enrolled Practice Location: 3435 Winchester Rd Ste 201, Allentown, PA 18104 Phone: 610-402-0100 | |
Dr. Joseph Thomas Termini, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 942 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-433-0404 | |
Madhavi Capoccia, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 115, Allentown, PA 18104 Phone: 610-395-0307 Fax: 610-395-0950 | |
Pavel Enrique Terreros, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1447 W Hamilton St, Allentown, PA 18102 Phone: 610-434-4445 |